Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and oral administration.
The concentration-time profiles of metabolites of moxisylyte, an alpha-blocking agent, in the plasma and urine of 12 healthy volunteers were investigated after intravenous (iv) and oral (two formulations) administration. The study was conducted with an open, randomized Latin squares design. Plasma and urine levels of moxisylyte and its biotransformation products were assayed by a specific HPLC method with fluorescence detection. Plasma levels declined in a monophasic or biphasic pattern depending on the subject. Two metabolites, conjugated desacetylmoxisylyte (DAM) and conjugated monodesmethylated DAM (MDAM), were found in plasma and urine. Unconjugated DAM was found in plasma only after iv administration. The apparent elimination half-lives of unconjugated DAM, conjugated DAM, and MDAM were 0.86, 1.7, and 3 h, respectively. The total amounts of metabolites (expressed as the equivalent of DAM) excreted in the urine were 75% after i.v. administration and 68 and 69% after oral administration of the two formulations. Oral absorption appeared to be complete for the two treatments. There was no statistical difference between the two oral formulations studied.
Costa
P
P
Service d'Urologie Andrologie, Centre Hospitalier Universitaire, Nîmes, France.
Bressolle
F
F
Bromet-Petit
M
M
Mosser
J
J
Sarrazin
B
B
D000284:Administration, Oral; D000328:Adult; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D013948:Moxisylyte / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D014551:Urinary Tract / Q000378:metabolism
D013948:Moxisylyte